Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning

Free Radical Biology and Medicine

Volumn 34, Issue 1, 2003, Pages 33-43

  Pagliaro, Pasquale ^a   Mancardi, Daniele ^a   Rastaldo, Raffaella ^a   Penna, Claudia ^a   Gattullo, Donatella ^a   Miranda, Katrina M ^b   Feelisch, Martin ^c   Wink, David A ^b   Kass, David A ^d   Paolocci, Nazareno ^d  

^a UNIVERSITY OF TURIN   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Louisiana State Health Sciences Center   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Angeli's salt; Diethylamine NO complex; Free radicals; Ischemia reperfusion; Myocardial necrosis; N acetyl L cysteine; Nitric oxide; Nitroxyl; Preconditioning

Indexed keywords

ACETYLCYSTEINE; ANGELI SALT; BUFFER; DIETHYLAMINE; INOTROPIC AGENT; LACTATE DEHYDROGENASE; NITRIC OXIDE; NITROXYL; REACTIVE NITROGEN SPECIES; SODIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DECOMPOSITION; DRUG EFFECT; ENZYME RELEASE; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL REPERFUSION INJURY; NITROGEN OXIDES; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS;

EID: 12244282420     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01179-6     Document Type: Article

References (64)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
2. Downey J.M., Cohen M.V. Signal transduction in ischemic preconditioning. Adv Exp Med Biol. 430:1987;39-55.
3. Bolli R. The late phase of preconditioning. Circ Res. 87:2000;972-983.
4. Pagliaro P., Gattullo D., Rastaldo R., Losano G. Ischemic preconditioning from the first to the second window of protection. Life Sci. 69:2001;1-15.
5. Marber M.S., Latchman D.S., Walker J.M., Yellon D.M. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 88:1993;1264-1272.
6. Tang X.L., Qiu Y., Park S.W., Sun J.Z., Kalya A., Bolli R. Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res. 79:1996;424-434.
7. Baxter G.F., Goma F.M., Yellon D.M. Characterisation of the infarct-limiting effect of delayed preconditioning timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol. 92:1997;159-167.
8. Bolli R., Bhatti Z.A., Tang X.L., Qiu Y., Zhang Q., Guo Y., Jadoon A.K. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 81:1997;42-52.
9. Takano H., Tang X.L., Qiu Y., Guo Y., French B.A., Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res. 83:1998;73-84.
10. Hill M., Takano H., Tang X.L., Kodani E., Shirk G., Bolli R. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation. 104:2001;694-699.
11. Hu C.-P., Li Y.-J., Deng H.-W. The cardioprotective effects of nitroglycerin-induced preconditioning are mediated by calcitonin gene-related peptide. Eur J Pharmacol. 369:1999;189-194.
12. Sasaki N., Sato T., Ohler A., O'Rourke B., Marban E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation. 101:2000;439-445.
13. Gattullo D., Linden R.J., Losano G., Pagliaro P., Westerhof N. Ischaemic preconditioning changes the pattern of coronary reactive hyperaemia in the goat role of adenosine and nitric oxide. Cardiovasc Res. 42:1999;57-64.
14. Patel V.C., Yellon D.M., Singh K.J., Neidl G.H., Woolfson R.G. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem Biophys Res Commun. 194:1993;234-238.
15. Schulz R., Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res. 30:1995;432-439.
16. Woolfson R.G., Patel V.C., Neild G.H., Yellon D.M. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation. 91:1995;1545-1551.
17. Weselcouch E.O., Baird A.J., Sleph P., Grover G.J. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol. 268:1995;H242-H249.
18. Nakano A., Liu G.S., Heusch G., Downey J.M., Cohen M.V. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol. 32:2000;1159-1167.
19. Miranda K., Espey M.G., Jourd'heuil D., Grisham M.B., Fukuto M., Feelisch M., Wink D.A. The chemical biology of nitric oxide. Ignarro L.J. Nitric oxide biology and pathobiology. 2000;41-55 Academic Press, San Diego, London.
20. Xia Y., Zweier J.L. Direct measurement of nitric oxide generation from nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 94:1997;12705-12710.
21. Hobbs A.J., Fukuto J.M., Ignarro L.J. Formation of free nitric oxide from l-arginine by nitric oxide synthase direct enhancement of generation by superoxide dismutase. Proc. Natl. Acad. Sci. USA. 91:1994;10992-10996.
22. G-hydroxyl-L-arginine by purified nitric oxide synthase. Biochemistry. 34:1995;1930-1941.
23. Schmidt H.H.H.W., Hoffmann H., Schindler U., Shutenko Z.S., Cunningham D.D., Feelisch M. No NO from NO synthase. Proc. Natl. Acad. Sci. USA. 93:1996;14492-14497.
24. Maragos C.M., Morley D., Wink D.A., Dunams T.M., Saavedra J.E., Hoffman A., Bove A.A., Isaac L., Hrabie J.A., Keefer L.K. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem. 34:1991;3242-3247.
25. Fukuto J.M., Cho J.Y., Switzer C.H. The chemical properties of nitric oxide and related nitrogen oxides. Ignarro L.J. Nitric oxide biology and pathobiology. 2000;23-40 Academic Press, San Diego, London.
26. Wink D.A., Feelisch M., Fukuto J., Chistodoulou D., Jourd'heuil D., Grisham M.B., Vodovotz Y., Cook J.A., Krishna M., DeGraff W.G., Kim S., Gamson J., Mitchell J.B. The cytotoxicity of nitroxyl possible implications for the pathophysiological role of NO. Arch Biochem Biophys. 351:1998;66-74.
27. Ma X.L., Gao F., Liu G.-L., Lopez B.L., Christopher T.A., Fukuto J.M., Wink D.A., Feelisch M. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc. Natl. Acad. Sci. USA. 96:1999;14617-14622.
28. Colton C.A., Gbadegesin M., Wink D.A., Miranda K.M., Espey M.G., Vicini S. Nitroxyl anion regulation of the NMDA receptor. J Neurochem. 78:2001;1126-1134.
29. Paolocci N., Saavedra W.F., Miranda K.M., Martignani C., Isoda T., Hare J.M., Espey M.G., Fukuto J.M., Feelisch M., Wink D.A., Kass D.A. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc. Natl. Acad. Sci. USA. 98:2001;10463-10468.
30. Rastaldo R., Paolocci N., Chiribiri A., Penna C., Gattullo D., Pagliaro P. Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect. Am J Physiol Heart Circ Physiol. 280:2001;H2823-H2832.
31. Paolocci N., Ekelund U.E., Isoda T., Ozaki M., Vandegaer K., Georgakopoulos D., Harrison R.W., Kass D.A., Hare J.M. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors potential role for nitrosylation. Am J Physiol Heart Circ Physiol. 279:2000;H1982-H1988.
32. Chen W., Gabel S., Steenbergen C., Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res. 77:1995;424-429.
33. Muller-Strahl G., Kottenberg K., Zimmer H.G., Noack E., Kojda G. Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart. J Physiol. 522:2000;311-320.
34. Tani M., Suganuma Y., Takayama M., Hasegawa H., Shinmura K., Ebihara Y., Tamaki K. Low concentrations of adenosine receptor blocker decrease protection by hypoxic preconditioning in ischemic rat hearts. J Mol Cell Cardiol. 30:1998;617-626.
35. Wang Y., Takashi E., Xu M., Ayub A., Ashraf M. Downregulation of protein kinase C inhibits activation of mitochondrial K(ATP) channels by diazoxide. Circulation. 104:2001;85-90.
36. Cohen M.V., Yang X.M., Downey J.M. Smaller infarct after preconditioning does not predict extent of early functional improvement of reperfused heart. Am J Physiol. 277:1999;H1754-H1761.
37. Hare J.M., Kim B., Flavahan N.A., Ricker K.M., Peng X., Colman L., Weiss R.G., Kass D.A. Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart. J Clin Invest. 101:1998;1424-1431.
38. Weselcouch E.O., Baird A.J., Sleph P.G., Dzwonczyk S., Murray H.N., Grover G.J. Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart. Cardiovasc Res. 29:1995;126-132.
39. Bergmeyer H.U., Bernt E. Methods of enzymatic analysis. 1974;Verlag Chemie, Weinheim, Germany.
40. Gelpi R.J., Morales C., Choen M.V., Downey J.M. Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol. 97:2002;40-46.
41. Altup S., Demiryurek A.T., Ak D., Tungel M., Kanzik I. Contribution of peroxynitrite to the beneficial effects of preconditioning on ischaemia-induced arrhythmias in rat isolated hearts. Eur J Pharmacol. 415:2001;239-246.
42. Conska C., Csont T., Onody A., Ferdinandy P. Preconditioning decreases ischemia/reperfusion-induced peroxynitrite formation. Biochem Biophys Res Commun. 285:2001;1217-1219.
43. Altug S., Demiryurek A.T., Kane K.A., Kanzik I. Evidence for the involvement of peroxynitrite on ischemic preconditioning in rat isolated hearts. Br J Pharmacol. 130:2000;125-131.
44. Ma X.L., Gao F., Lopez B.L., Christopher T.A., Vinten-Johansen J. Peroxynitrite, a two-edged sword in post-ischemic myocardial injury-dichotomy of action in crystalloid- versus blood-perfused hearts. J Pharmacol Exp Ther. 292:2000;912-920.
45. Miranda K.M., Espey M.G., Yamada K., Krishna M., Ludwick N., Kim S., Jourd'heuil D., Grisham M.B., Feelisch M., Fukuto J.M., Wink D.A. Unique oxidative mechanisms for the reactive nitrogen species, nitroxyl anion. J Biol Chem. 276:2001;1720-1727.
46. ATP channels or reactive oxygen species? Cardiovasc Res. 51:2001;633-636.
47. Miranda K.M., Yamada K.-I., Thomas D.D., DeGraff W., Espey M.G., Krishna M., Mitchell J.B., Colton C.A., Wink D.A. Further evidence for distinctive reactive intermediates from nitroxyl and peroxynitrite effects of buffer conditions on the chemistry of angeli's salt and synthetic peroxynitrite. Arch Biochem Biophys. 401:2002;134-144.
48. Lawrence C.L., Billups B., Rodrigo G.C., Standen N.B. The K(ATP) channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation. Br J Pharmacol. 134:2001;535-542.
49. Forbes R.A., Steenbergen C., Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res. 88:2001;802-809.
50. ATP channels protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovasc Res. 51:2001;691-700.
51. ATP channel induces early and delayed cardioprotective effect: role of nitric oxide. Am J Physiol. 277:1999;H2425-H2434.
52. Wei E.P., Kontos H.A., Beckman J.S. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide and peroxynitrite. Am J Physiol. 271:1996;H1262-H1266.
53. ATP channels triggers the preconditioned state by generating free radicals. Circ Res. 87:2000;460-466.
54. Cohen M.V., Yang X.M., Liu G.S., Heusch G., Downey J.M. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res. 89:2001;273-278.
55. Inagaki K., Kihara Y., Hayashida W., Izumi T., Iwanaga Y., Yoneda T., Takeuchi Y., Suyama K., Muso E., Sasayama S. Anti-ischemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of delta-isoform of protein kinase C in rat ventricular myocardium. Circulation. 101:2000;797-804.
56. Li Y.J., Peng J. The cardioprotection of calcitonin gene-related peptide-mediated preconditioning. Eur J Pharmacol. 442:2002;173-177.
57. Tritto I., Ambrosio G. Role of oxidants in the signaling pathway of preconditioning. Antioxid Redox Signal. 3:2001;3-10.
58. 2+ responses in intact hearts. Am J Physiol Heart Circ Physiol. 281:2001;H1508-H1523.
59. Balligand J.-L., Feron O., Kelly R.A. Role of nitric oxide in myocardial function. Ignarro L.J. Nitric oxide biology and pathobiology. 2000;585-632 Academic Press, San Diego, London.
60. Miranda, K. M.; Nims, R. W.; Thomas, D. D.; Espey, M. G.; Citrin, D.; Bartberger, M. D.; Paolocci, N.; Fukuto, J. M.; Feelisch, M.; Wink, D. A. Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related products of NOS. J. Inorg. Biochem. in press; 2002.
61. -) using L-cysteine. Biochem Biophys Res Commun. 201:1994;54-62.
62. Ellis A., Li C.G., Rand M.J. Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta. Br J Pharmacol. 129:2000;315-322.
63. Reif A., Zecca L., Riederer P., Feelisch M., Schmidt H.H. Nitroxyl oxidizes NADPH in a superoxide dismutase inhibitable manner. Free Radic Biol Med. 30:2001;803-808.
64. Wong P.S.-Y., Hyun J., Fukuto J.M., Shirota F.N., DeMaster E.G., Shoeman D.W., Nagasawa H.T. Reaction between S-nitrosothiols and thiols generation of nitroxyl (HNO) and subsequent chemistry. Biochemistry. 37:1998;5362-5371.